Charite N. Ricker, MS, CGC

Assistant Professor Of Clinical Medicine

Image of Charite N. Ricker, MS, CGC
Is this your profile? Click to edit


Charité Ricker, MS is a genetic counselor with the USC Norris Comprehensive Cancer Center and Clinical Instructor of Medicine in the USC Keck School of Medicine. She leads the genetic counseling team at Los Angeles General Medical Center for individuals and family at risk of having inherited cancer syndromes.

Ms. Ricker has extensive experience as a cancer genetic counselor and the majority of her clinical work has been in the underserved patient setting. Her particular research interest is focused on the provision of genetic services to ethnically diverse patient populations and its impact and the outcomes.


  • Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares Transl Behav Med. 2022 01 18; 12(1). . View in PubMed
  • PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California J Cancer Res Clin Oncol. 2021 Jun; 147(6):1803-1811. . View in PubMed
  • A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma Cureus. 2021 Jun; 13(6):e15480. . View in PubMed
  • Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors J Genet Couns. 2021 04; 30(2):342-360. . View in PubMed
  • A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors J Genet Couns. 2021 04; 30(2):394-405. . View in PubMed
  • BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study J Genet Couns. 2021 04; 30(2):383-393. . View in PubMed
  • Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients Cancer. 2021 04 15; 127(8):1275-1285. . View in PubMed
  • Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites Elife. 2021 06 22; 10. . View in PubMed
  • Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 12; 159(3):869-876. . View in PubMed
  • Management of Male Breast Cancer: ASCO Guideline J Clin Oncol. 2020 06 01; 38(16):1849-1863. . View in PubMed
  • Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation BMJ Case Rep. 2019 Jun 20; 12(6). . View in PubMed
  • Clinical findings and outcomes of MRI staging of breast cancer in a diverse population Breast Cancer Res Treat. 2019 Apr; 174(2):315-324. . View in PubMed
  • Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk JCO Precis Oncol. 2019 Mar; 3. . View in PubMed
  • Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer Cancer. 2019 08 15; 125(16):2829-2836. . View in PubMed
  • Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series Gynecol Oncol Rep. 2018 Aug; 25:98-101. . View in PubMed
  • Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature Health Aff (Millwood). 2018 05; 37(5):801-808. . View in PubMed
  • Patient communication of cancer genetic test results in a diverse population Transl Behav Med. 2018 01 29; 8(1):85-94. . View in PubMed
  • Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature Front Oncol. 2018; 8:259. . View in PubMed
  • DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer Cancer. 2017 Oct 01; 123(19):3732-3743. . View in PubMed
  • Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome Cancer Genet. 2017 04; 212-213:1-7. . View in PubMed
  • Genomic Disparities in Breast Cancer Among Latinas Cancer Control. 2016 Oct; 23(4):359-372. . View in PubMed
  • Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort Cancer Genet. 2016 Apr; 209(4):130-7. . View in PubMed
  • Haplotype analyses of the c1027C>T and c. 2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2. Breast Cancer Res Treat. 2016 11; 160(1):121-129. . View in PubMed
  • Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network J Clin Oncol. 2013 Jan 10; 31(2):210-6. . View in PubMed
  • Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment Fam Cancer. 2012 Sep; 11(3):449-58. . View in PubMed
  • Pathological characteristics of BRCA-associated breast cancers in Hispanics Breast Cancer Res Treat. 2011 Nov; 130(1):281-9. . View in PubMed
  • Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer Psychooncology. 2008 Aug; 17(8):774-82. . View in PubMed
  • Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1615-20. . View in PubMed
  • Beliefs and interest in cancer risk in an underserved Latino cohort Prev Med. 2007 Mar; 44(3):241-5. . View in PubMed
  • . . will they come?–establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns. 2006 Dec; 15(6):505-14. . View in PubMed
  • Prevalence of BRCA mutations and founder effect in high-risk Hispanic families Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1666-71. . View in PubMed
  • Outcomes from intensive training in genetic cancer risk counseling for clinicians Genet Med. 2005 Jan; 7(1):40-7. . View in PubMed